Thomas Jefferson University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Thomas Jefferson University sits in the top decile of US sponsors by registered trial count (#118 of 15,742 sponsors by registered trial count).
Thomas Jefferson University: 292 sponsored US clinical trials, 54 recruiting.
Thomas Jefferson University sponsors 292 registered US clinical trials on ClinicalTrials.gov, 54 of them currently recruiting, and 182 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Malignant Solid Neoplasm, with 4 trials.
Top-decile sponsor footprint
Thomas Jefferson University ranks in the top decile of sponsors by registered trial count (#118 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
182 of 210 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
292 total, page 2 of 6
Head to Head Comparison of Upper Airway Stimulation and Continuous Positive Airway Pressure; a Pilot Study.
NCT04191512
Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops
NCT03911531
Prospective Breast Cancer Biospecimen Collection
NCT04074720
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
NCT03245411
Analgesic Techniques for Rib Fractures
NCT06519929
Developing a Nutrition Support Assessment Tool
NCT06450860
A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa
NCT07462403
Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome
NCT05564650
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
NCT05336786
Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity
NCT05669508
Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases
NCT04728633
Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
NCT05117541
A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
NCT05055323
Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers
NCT05132881
Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer
NCT04719273
Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound
NCT04643431
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
NCT04111172
An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment
NCT04447716
FDOPA PET and Nutritional Support in Parkinson's Disease
NCT04459052
NuroSleeve Powered Brace & Stimulation System to Restore Arm Function
NCT04798378
Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study
NCT04789018
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
NCT03854032
Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy
NCT06425575
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NCT04086875
Entecavir to TAF Switch
NCT03489239
PET Imaging of Chronic Pain Syndromes
NCT03233594
Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome
NCT03370614
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
NCT02023463
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
NCT06024772
Periprosthetic Joint Infection Bubble Study
NCT07599865
The IMPACT Study: Personalized Physical Therapy for Better Recovery and a Stronger Core After Hernia Surgery
NCT07145099
Ketamine for the Treatment of Refractory Status Epilepticus
NCT07177235
Psychological Burden of Thyroid Eye Disease
NCT07444190
SHAPE for ICP Assessment
NCT06571786
MBC Physical Activity Study
NCT06500858
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
NCT06315296
Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer
NCT06219434
AMBU Bag Manual Ventilation vs. Transport Ventilator Mechanical Ventilation for Transport
NCT06006208
Combined Therapeutic Air Mixture and Electrical Stimulation to Improve Breathing and Hand Function in Spinal Cord Injury
NCT06101199
Measuring Pain Experience in Individuals With Lateral Elbow Tendinopathy
NCT06025565
ACT with NMOSD Patients and Caregivers Pilot Study
NCT05840055
LiSWT for Nerve Sparing Radical Prostatectomy ED
NCT05877144
Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma
NCT06041698
Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities
NCT06010355
Improving Patient Experience: BMBA
NCT05690230
Nursing-Driven Primary Palliative Care for Urban-Dwelling African Americans With Chronic Lung Disease
NCT05611125
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer
NCT05408260
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer
NCT05676463
Home Based Daratumumab Administration for Patients With Multiple Myeloma
NCT05511428
COVID Booster in Pregnancy and Lactation
NCT05543993
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 39 |
| Phase 2 | 34 |
| Phase 3 | 19 |
| Phase 4 | 27 |
What is open in the Thomas Jefferson University pipeline
54 recruiting of 292 indexed (18% open); 182 completed (62%).
Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).
Top condition: Malignant Solid Neoplasm (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Thomas Jefferson University: open-pipeline peers nationwide
Peers matched on 292 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Thomas Jefferson University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 292 trials (± recruiting share)
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- University of Missouri-Columbia · 291 trials · 19% recruiting
- Kaiser Permanente · 294 trials · 7% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Florida Atlantic University · 19% recruiting · 27 trials
- Institut de Recherches Internationales Servier · 19% recruiting · 27 trials
- Natera · 19% recruiting · 27 trials
- Nemours Children's Clinic · 19% recruiting · 108 trials
Related
What to do with this Thomas Jefferson University page
292 registered trials is a research-attention snapshot, not an endorsement of Thomas Jefferson University or any single study.
- 54 of Thomas Jefferson University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Malignant Solid Neoplasm is the condition Thomas Jefferson University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Malignant Solid Neoplasm trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Thomas Jefferson University pipeline card: 292 registered trials from official public datasets.Report a data error.